These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 27464697)

  • 1. Mouse and Cotton Rat Models of Human Respiratory Syncytial Virus.
    Rudd PA; Chen W; Mahalingam S
    Methods Mol Biol; 2016; 1442():209-17. PubMed ID: 27464697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of antiviral efficacy against human respiratory syncytial virus using cotton rat and mouse models.
    Van den Berg J; Kwanten L; Roymans D
    Methods Mol Biol; 2013; 1030():365-72. PubMed ID: 23821282
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Rijsbergen LC; Rennick LJ; Laksono BM; van Run PRWA; Kuiken T; Duprex WP; de Swart RL; de Vries RD
    J Gen Virol; 2020 Oct; 101(10):1037-1046. PubMed ID: 32692644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CX3CR1 Is a Receptor for Human Respiratory Syncytial Virus in Cotton Rats.
    Green G; Johnson SM; Costello H; Brakel K; Harder O; Oomens AG; Peeples ME; Moulton HM; Niewiesk S
    J Virol; 2021 Jul; 95(16):e0001021. PubMed ID: 34037420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant subtype A and B human respiratory syncytial virus clinical isolates co-infect the respiratory tract of cotton rats.
    Rennick LJ; Nambulli S; Lemon K; Olinger GY; Crossland NA; Millar EL; Duprex WP
    J Gen Virol; 2020 Oct; 101(10):1056-1068. PubMed ID: 32723429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant subgroup B human respiratory syncytial virus expressing enhanced green fluorescent protein efficiently replicates in primary human cells and is virulent in cotton rats.
    Lemon K; Nguyen DT; Ludlow M; Rennick LJ; Yüksel S; van Amerongen G; McQuaid S; Rima BK; de Swart RL; Duprex WP
    J Virol; 2015 Mar; 89(5):2849-56. PubMed ID: 25540371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis, Humoral Immune Responses, and Transmission between Cohoused Animals in a Ferret Model of Human Respiratory Syncytial Virus Infection.
    Chan KF; Carolan LA; Druce J; Chappell K; Watterson D; Young P; Korenkov D; Subbarao K; Barr IG; Laurie KL; Reading PC
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29187546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal models of human respiratory syncytial virus disease.
    Bem RA; Domachowske JB; Rosenberg HF
    Am J Physiol Lung Cell Mol Physiol; 2011 Aug; 301(2):L148-56. PubMed ID: 21571908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzimidazole analogs inhibit respiratory syncytial virus G protein function.
    Evans CW; Atkins C; Pathak A; Gilbert BE; Noah JW
    Antiviral Res; 2015 Sep; 121():31-8. PubMed ID: 26116756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of Respiratory Syncytial Virus (RSV) Memphis Strain 37 (M37) Infection in the Respiratory Tract of Newborn Lambs as an RSV Infection Model for Human Infants.
    Larios Mora A; Detalle L; Van Geelen A; Davis MS; Stohr T; Gallup JM; Ackermann MR
    PLoS One; 2015; 10(12):e0143580. PubMed ID: 26641081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-dependent replication of respiratory syncytial virus in the cotton rat.
    Curtis SJ; Ottolini MG; Porter DD; Prince GA
    Exp Biol Med (Maywood); 2002 Oct; 227(9):799-802. PubMed ID: 12324660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo evaluation of antiviral compounds on respiratory syncytial virus using a juvenile vervet monkey (Chlorocebus pygerythrus) infection model.
    Houspie L; Stevens H; Ngotho M; Keyaerts E; Ispas G; Verloes R; Van Ranst M; Maes P
    Methods Mol Biol; 2013; 1030():373-82. PubMed ID: 23821283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute and Chronic Airway Disease After Human Respiratory Syncytial Virus Infection in Cotton Rats (Sigmodon hispidus).
    Grieves JL; Yin Z; Durbin RK; Durbin JE
    Comp Med; 2015 Aug; 65(4):315-26. PubMed ID: 26310461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Animal models of respiratory syncytial virus infection.
    Taylor G
    Vaccine; 2017 Jan; 35(3):469-480. PubMed ID: 27908639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal nanoemulsion-based inactivated respiratory syncytial virus vaccines protect against viral challenge in cotton rats.
    O'Konek JJ; Makidon PE; Landers JJ; Cao Z; Malinczak CA; Pannu J; Sun J; Bitko V; Ciotti S; Hamouda T; Wojcinski ZW; Lukacs NW; Fattom A; Baker JR
    Hum Vaccin Immunother; 2015; 11(12):2904-12. PubMed ID: 26307915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single, low dose of a cGMP recombinant BCG vaccine elicits protective T cell immunity against the human respiratory syncytial virus infection and prevents lung pathology in mice.
    Céspedes PF; Rey-Jurado E; Espinoza JA; Rivera CA; Canedo-Marroquín G; Bueno SM; Kalergis AM
    Vaccine; 2017 Feb; 35(5):757-766. PubMed ID: 28065474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery of ALX-0171 by inhalation greatly reduces respiratory syncytial virus disease in newborn lambs.
    Larios Mora A; Detalle L; Gallup JM; Van Geelen A; Stohr T; Duprez L; Ackermann MR
    MAbs; 2018 Jul; 10(5):778-795. PubMed ID: 29733750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respiratory syncytial virus infects and abortively replicates in the lungs in spite of preexisting immunity.
    Boukhvalova MS; Prince GA; Blanco JC
    J Virol; 2007 Sep; 81(17):9443-50. PubMed ID: 17596309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral efficacy of a respiratory syncytial virus inhibitor in rodent models of infection.
    Cianci C; Genovesi EV; Lamb L; Medina I; Yang Z; Zadjura L; Yang H; D'Arienzo C; Sin N; Yu KL; Combrink K; Li Z; Colonno R; Meanwell N; Clark J; Krystal M
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2448-54. PubMed ID: 15215093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting human respiratory syncytial virus transcription anti-termination factor M2-1 to inhibit in vivo viral replication.
    Bailly B; Richard CA; Sharma G; Wang L; Johansen L; Cao J; Pendharkar V; Sharma DC; Galloux M; Wang Y; Cui R; Zou G; Guillon P; von Itzstein M; Eléouët JF; Altmeyer R
    Sci Rep; 2016 May; 6():25806. PubMed ID: 27194388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.